Psychiatry
RCT: Comparison of nebulized ketamine at three different dosing regimens for treating painful conditions in the emergency department.
13 Jul, 2021 | 09:22h | UTCComparison of Nebulized Ketamine at Three Different Dosing Regimens for Treating Painful Conditions in the Emergency Department: A Prospective, Randomized, Double-Blind Clinical Trial – Annals of Emergency Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Nebulized Ketamine for pain in the ED? No way…Well- here you go-Comparison of Nebulized Ketamine at Three Different Dosing Regimens for Treating Painful Conditions in the ED. https://t.co/v3UT0Y0LdU #FOAMed #FOAMems #FOAMtox #FOAMcc #FOAMpharm
— Sergey Motov (@painfreeED) July 3, 2021
M-A: Continuation of antidepressants vs. sequential psychological interventions to prevent relapse in depression.
8 Jul, 2021 | 08:50h | UTCContinuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression: An Individual Participant Data Meta-analysis – JAMA Psychiatry (link to abstract – $ for full-text)
Commentaries: Cognitive Therapy While Tapering Antidepressants May Be Alternative to Maintenance Medication – Psychiatric News Alert AND Psychotherapy Can Prevent Relapse When Discontinuing Antidepressants – Mad in America
Commentary on Twitter
Sequential delivery of a psychological intervention while tapering antidepressants may be a potential alternative to long-term medication use in recurrent #depression, regardless of clinical risk factors @JosefienUMH, @Claudib123 https://t.co/UURRmv6qQO
— JAMA Psychiatry (@JAMAPsych) May 19, 2021
RCT: A prevention program for insomnia in at-risk adolescents.
7 Jul, 2021 | 08:38h | UTCA Prevention Program for Insomnia in At-risk Adolescents: A Randomized Controlled Study – Pediatrics (link to abstract – $ for full-text)
Commentaries: Using a program to combat teen insomnia – Contemporary Pediatrics AND Cognitive behavioral program may prevent insomnia in at-risk adolescents – Medicom
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations.
5 Jul, 2021 | 01:30h | UTCAntipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations – Drugs
The Management of Restless Legs Syndrome: An Updated Algorithm
2 Jul, 2021 | 11:12h | UTCThe Management of Restless Legs Syndrome: An Updated Algorithm – Mayo Clinic Proceedings
Perspective | “Prohibitive policies cause more problems than illict drugs, say experts”
2 Jul, 2021 | 11:07h | UTCProhibitive Policies Cause More Problems Than Illict Drugs, Say Experts – Health Policy Watch
The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection.
1 Jul, 2021 | 09:55h | UTC
Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department.
28 Jun, 2021 | 09:43h | UTC
Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds.
25 Jun, 2021 | 10:33h | UTCOriginal Study: Long COVID in a prospective cohort of home-isolated patients – Nature Medicine
Commentary on Twitter
Analysis of a prospectively enrolled cohort of patients with #SARSCoV2 infections reveals a high proportion who experienced #LongCovid symptoms at 6 months, despite being relatively young and having only mild to moderate acute #COVID19 symptoms https://t.co/fuW2QpfJog
— Nature Medicine (@NatureMedicine) June 23, 2021
One in 100 deaths is by suicide – WHO guidance to help the world reach the target of reducing suicide rate by 1/3 by 2030.
21 Jun, 2021 | 08:39h | UTCOne in 100 deaths is by suicide – World Health Organization
Report: Suicide worldwide in 2019: Global Health Estimates – World Health Organization
Commentary on Twitter (thread – click for more)
DYK: 1 in 100 deaths is by suicide.
Every year, more people die as a result of suicide than HIV, malaria or breast cancer – or war and homicide. https://t.co/PAD5Bd1dfS pic.twitter.com/TGq5BdNMNd
— World Health Organization (WHO) (@WHO) June 17, 2021
Report: 376,000 people in UK have had long Covid symptoms for at least a year.
8 Jun, 2021 | 09:27h | UTC376,000 people in UK have had long Covid symptoms for at least a year – ONS – The Guardian
Original report: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 June 2021 – Office for National Statistics
2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.
6 Jun, 2021 | 23:54h | UTCNeurologic, psychiatric conditions common in COVID-19 – CIDRAP
More data on the harmful effects of the COVID-19 pandemic on the mental health of adolescents.
6 Jun, 2021 | 23:52h | UTCCommentaries: A lost generation? COVID-19 and adolescent mental health – The Lancet Psychiatry AND COVID-19 pandemic has had significant impact on the mental health of adolescents – Columbia University Mailman School of Public Health
Commentary on Twitter (thread – click for more)
"Evidence in support of an increase in mental health problems among adolescents during #COVID19 is accumulating, with girls and older adolescents disproportionately negatively affected."
New #Free Researchhttps://t.co/kcmPGbUrIX
— The Lancet Psychiatry (@TheLancetPsych) June 4, 2021
ACP offers guidance on physician suicide prevention and the role of a healing community from an ethics perspective.
3 Jun, 2021 | 10:45h | UTC
Systematic review: Driving performance under treatment of most frequently prescribed drugs for mental disorders – 31% of schizophrenic or schizoaffective patients under antipsychotics, and 18% of unipolar and bipolar patients under antidepressants showed severe impairment in skills relevant for driving.
2 Jun, 2021 | 08:24h | UTC
COVID has caused ‘mass trauma,’ worsening mental health globally.
1 Jun, 2021 | 08:14h | UTCCOVID Has Caused ‘Mass Trauma,’ Worsening Mental Health Globally – Health Policy Watch
Viewpoint | A population-level approach to suicide prevention.
28 May, 2021 | 08:12h | UTCA Population-Level Approach to Suicide Prevention – JAMA
Systematic review of 45 studies including 9751 participants, most of which were hospitalized, found 73% had at least 1 persistent symptom for weeks after Covid-19.
27 May, 2021 | 08:37h | UTCCommentary: Seven out of ten hospitalized COVID-19 patients will have long-haul symptoms – MedicalXpress
Count the cost of disability caused by COVID-19 – “Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies”.
27 May, 2021 | 08:35h | UTCCount the cost of disability caused by COVID-19 – Nature
COVID Morbidity – The emerging burden of long COVID is significant, and needs to be considered when evaluating the risk vs. benefit of pandemic measures.
27 May, 2021 | 08:34h | UTCCOVID Morbidity – Science-Based Medicine
Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work.
26 May, 2021 | 08:18h | UTC
AAP Clinical Report: Collaborative care in the identification and management of psychosis in adolescents and young adults.
25 May, 2021 | 08:41h | UTC
Meta-analysis: New generation antidepressants for depression in children and adolescents – “most newer antidepressants may reduce depression symptoms in a small and unimportant way compared with placebo”.
25 May, 2021 | 08:40h | UTC
[Preprint] No safe level of alcohol consumption for brain health: observational cohort study of 25,378 UK Biobank participants.
24 May, 2021 | 08:20h | UTCCommentaries: Drinking any amount of alcohol causes damage to the brain, study finds – CNN AND Expert reaction to a preprint looking at alcohol consumption and brain health – Science Media Centre AND Any amount of alcohol consumption harmful to the brain, finds study – The Guardian
Clinical review: Treatment of opioid use disorder in primary care.
21 May, 2021 | 08:31h | UTCTreatment of opioid use disorder in primary care – The BMJ (free for a limited period)